A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Local Institution - 0005, Santiago

Local Institution - 0035, CABA

Local Institution - 0025, CABA

Local Institution - 0040, Rotorua

Local Institution - 0015, Tauranga

Local Institution - 0018, Newtown

Local Institution - 0014, Dunedin

Local Institution - 0048, Mexico City

Local Institution - 0003, Rozzano

Local Institution - 0024, Rockville

Local Institution - 0017, Madrid

Local Institution - 0001, Charlotte

Local Institution - 0016, Málaga

Greenville Health System, Greenville

Winship Cancer Institute., Atlanta

Local Institution - 0004, Padua

Local Institution - 0022, Saint-Herblain

Local Institution - 0046, Monterrey

Local Institution - 0047, Monterrey

Local Institution - 0049, Puebla City

Local Institution - 0007, Dallas

Local Institution - 0011, Tyler

Local Institution - 0045, Querétaro

Local Institution - 0010, Austin

Local Institution - 0021, Villejuif

Local Institution - 0012, Eugene

Local Institution - 0038, Porto Alegre

Local Institution - 0020, Detroit

Local Institution - 0009, Beaumont

Local Institution - 0037, São Paulo

Local Institution - 0050, Mexico City

Local Institution - 0026, Amsterdam

Local Institution - 0039, Maastricht

Local Institution - 0019, Warsaw

Local Institution - 0033, Cardiff

Local Institution - 0031, Liverpool